Morin et al. performed WES of 38 relapsed/refractory DLBCL and detected TP53, FOXO1, KMT2C, CCND3, NFKBIZ, and STAT6 as top candidate genes in which mutations were related to treatment resistance [12]. Here, TP53 is linked to diffuse large B-cell lymphoma.